Pharmacokinetic Models [Design Issues]

posted by venu  – Mumbai, India, 2007-02-14 06:00 (7072 d 14:01 ago) – Posting: # 515
Views: 5,762

Hi,

In BA/BE studies, why only 2x2 crossover design noncompartmental models are used in most of the pilot and pivotal studies? :-)

When can you use the compartmental models in the BA/BE stuides? Does the use of these compartmental models depend on the nature of the generic drugs.

Please if you could provide more information in detail regarding the questions mentioned above. :-)

Venu

Best Regards,
Ms. Vandana Panchal
Biostatistician
Mumbai
India

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
346 visitors (0 registered, 346 guests [including 24 identified bots]).
Forum time: 21:02 CEST (Europe/Vienna)

Ignorance more frequently begets confidence
than does knowledge.    Charles Darwin

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5